Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank33
3Y CAGR-14.0%
5Y CAGR-42.4%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-14.0%/yr
Annual compound
5Y CAGR
-42.4%/yr
Recent acceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.09 | -10.3% |
| 2024 | 0.10 | -35.8% |
| 2023 | 0.15 | +10.4% |
| 2022 | 0.14 | - |
| 2021 | 0.00 | -100.0% |
| 2020 | 1.37 | +1930.0% |
| 2019 | 0.07 | - |